BIA
INDV icon

Bell Investment Advisors’s Indivior Pharmaceuticals INDV Stock Holding History

Bell Investment Advisors’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534 Buy
+13
New +$472 ﹤0.01% 1706
2026
Q1 		– Sell
-14
Closed -$503 – 1903
2025
Q4 		$503 Buy
+14
New +$427 ﹤0.01% 1742
2024
Q2 		– Sell
-22
Closed -$472 – 1953
2024
Q1 		$472 Buy
+22
New +$413 ﹤0.01% 1840

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bell Investment Advisors's INDV Position: Q2 2026 in Review

Bell Investment Advisors opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 13 shares worth $534. The stake represents ﹤0.01% of the portfolio and ranks #1706 among its holdings. This is a return to the name: Bell Investment Advisors previously reported a position in INDV as recently as Q4 2025.

Bell Investment Advisors first reported a position in INDV in Q1 2024 and has held it in 3 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Bell Investment Advisors held 13 shares of Indivior Pharmaceuticals worth $534 as of Q2 2026.
  • Indivior Pharmaceuticals was a new Bell Investment Advisors position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1706 holding.
  • Bell Investment Advisors first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.